Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 2221–2240 of 17,529 recalls

April 26, 2023· Akorn, Inc.

Recalled Item: Ropivacaine Hydrochloride Injection USP

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Moxifloxacin HCl Ophthalmic Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: DetomiSed (detomidine hydrochloride) packaged in a) 5mL and b)20mL vials

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Proparacaine HCl Ophthalmic Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Promethazine HCl Oral Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Trihexyphenidyl Hydrochloride Oral Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Ketorolac Tromethamine Ophthalmic Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Clobetasol Propionate Shampoo

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Lactulose Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Sufenta (Sufentanil Citrate Injection

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Acyclovir Oral Suspension

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Tropicamide Ophthalmic Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Neomycin & Polymyxin B Sulfates

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Acetic Acid Otic Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: DOCU LIQUID (docusate sodium

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Calcitriol Injection 2 mcg/mL

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Albuterol Sulfate Syrup

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Pilocarpine Hydrochloride Ophthalmic Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Oxcarbazepine Oral Suspension

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Olopatadine HCl Nasal Spray

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund